Our data suggest that ERK activation was important for the recovery of mTORC1 activity only in a subset of CR melanoma cell lines that express wild-type PTEN, where the RAS/ERK pathway is a major regulator of mTORC1. This evidence concerns the gene PTEN and melanoma.